Creon DR 36,000 unit capsule UU 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F1BQF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,376
Award facts
- Contract value 100% obligated
- $29,375.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100s, with a ceiling value of $29,375.94. This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
Creon is an FDA-approved pancreatic enzyme replacement therapy used to address pancreatic insufficiency and improve nutrient absorption in patients with cystic fibrosis, chronic pancreatitis, and pancreatic surgery outcomes. This delivery order exemplifies the breadth of pharmaceutical products that AmerisourceBergen provides to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through its established prime vendor arrangement with DLA. The non-set-aside competitive award status underscores AmerisourceBergen's demonstrated capability to meet federal medical procurement requirements across a diverse portfolio of specialty medications and medical commodities supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1BQF?
SPE2DR26F1BQF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F1BQF worth?
The government has obligated $29,376 on SPE2DR26F1BQF.
Is contract SPE2DR26F1BQF an order under another contract?
Yes. SPE2DR26F1BQF is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1BQF competed?
The extent of competition for SPE2DR26F1BQF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award